Preliminary evaluation of rat kidney aldose reductase inhibitory activity of 2-phenylindole derivatives: Affiliation to antioxidant activity

Medicinal Chemistry Research

Volumn 16, Issue 3, 2007, Pages 112-118

  Suzen, Sibel ^a   Das Evcimen, Net ^a   Varol, Pinar ^a   Sarikaya, Mutlu ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

2 phenylindole; Aldose reductase; Antioxidant; Diabetes mellitus; Inhibitory

Indexed keywords

2 PHENYLINDOLE DERIVATIVE; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; DRUG MECHANISM; DRUG SCREENING; DRUG STRUCTURE; ENZYME INHIBITION; ENZYME ISOLATION; MALE; NONHUMAN; RAT; SPECTROPHOTOMETRY;

EID: 38949203024     PISSN: 10542523     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00044-007-9014-y     Document Type: Article

References (26)

1. Anagnostou C, Nicolaou I, Demopoulos VJ (2002) Synthesis of [5-(4-pyrrol-1-yl-benzoyl)-1 H-pyrrol-2-yl)]-acetic acid and in vitro study of its inhibitory activity on aldose reductase enzyme and on protein glycation. Pharmazie 57:435-437
2. Blois MS (1958) Antioxidant determination by the use of stable free radical. Nature 181:1199-1200
3. Bozkaya P, Dogan B, Suzen S, Nebioglu D, Ozkan SA (2006) Determination and investigation of electrochemical behaviour of 2-phenylindole derivatives: discussion on possible mechanistic pathways. Can J Anal Sci Spec 51:125-139
4. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254
5. Buyukbingol E, Suzen S, Klopman G (1994) Studies on the synthesis and structure-activity relationships of 5-(3′-indolyl)-2-thiohydantoin derivatives as aldose reductase enzyme inhibitors. Il Farmaco 49:443-447
6. Cerelli KJ, Curtis DL, Dunn PH, Nelson PH, Peak TM, Waterbury LD (1986) Antiinflammatory and aldose reductase inhibitory activity of some tricyclic arylacetic acids. J Med Chem 29:2347-2351
7. da Settimo F, Primofiore G, Da Settimo A, La Motta C, Simorini F, Novellino E, Greco G, Lavecchia A, Boldrini E (2003) Novel, highly potent aldose reductase inhibitors: cyano(2-oxo-2,3-dihydroindol-3-yl)acetic acid derivatives. J Med Chem 46:1419-1428
8. Daş-Evcimen N, Pekiner B, Suzen S, Buyukbingol E (1998) The inhibitory effect of benzodiazepine derivatives on the bovine lens aldose reductase enzyme. Biochem Mol Biol Int 45:381-387
9. Demopoulos VJ, Nicolaou I, Zika C (2003) A facile preparation of 1-(6-hydroxyindol-1-yl)-2,2-dimethylpropan-1-one. Chem Pharm Bull (Tokyo) 51:98-99
10. Djoubissie PO, Snirc V, Sotnikova R, Zurova J, Kyselova Z, Skalska S, Gajdosik A, Javorkova V, Vlkovicova J, Vrbjar N, Stefek M (2006) In vitro inhibition of lens aldose reductase by (2-benzyl-2,3,4,5-tetrahydro-1 H-pyrido[4,3-b]indole-8-yl)-acetic acid in enzyme preparations isolated from diabetic rats. Gen Physiol Biophys 5:415-425
11. Droge W (2002) Free radicals in the physiological control of cell function Physiol Rev 82:47-95
12. Hashim Z, Zarina S (2006) Antioxidant markers in human senile and diabetic cataractous lenses. J Coll Phys Surg Pak 10:637-640
13. Klepac N, Rudes Z, Klepac R (2006) Effects of melatonin on plasma oxidative stress in rats with streptozotocin induced diabetes. Biomed Pharmacother 60:32-35
14. McCord J, Fridowich I (1969) An enzymic function for erythrocuprein. J Biol Chem 243:6049-6055
15. Narayanan S (1993) Aldose reductase and its inhibition in the control of diabetic complications. Ann Clin Lab Sci 23:148-158
16. Pau A, Asproni B, Boatto G, Grella GE, Caprariis P, De Costantino L, Pinna GA (2004) Synthesis and aldose reductase inhibitory activities of novel thienocinnolinone derivatives. Pharm Sci 21:545-552
17. Shabica AC, Howe EE, Zeigler JB, Tishler M (1946) Improved synthesis of indole-3-aldehyde. J Am Chem Soc 68:1156-1157
18. Shiriner RL, Ashies WC, Welch E (1955) Synthesis of 2-phenylindole. Org Synth 3:98-100
19. Spycher SE, Tabataba-Vakili S, O'Donnell VB, Palomba L, Azzi A (1997) Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J 11:181-188
20. Suzen S, Buyukbingol E (2003) Recent studies of aldose reductase enzyme inhibition for diabetic complications. Current Med Chem 10:1329-1352
21. Suzen S, Bozkaya P, Coban T, Nebioglu D (2006) Investigation of in vitro antioxidant behavior of some 2-phenylindole derivatives: discussion on possible antioxidant mechanisms and comparison with melatonin. J Enzyme Inh Med Chem 21:405-411
22. Traverso N, Menini S, Cosso L, Odetti P, Albano E, Pronzato E, Marinari UM (1998) Immunological evidence for increased oxidative stress in diabetic rats. Diabetologia 41:265-270
23. Traverso N, Menini S, Odetti P, Pronzato MA, Cottalasso D, Marinari UM (1999) Lipoperoxidation in hepatic subcellular compartments of diabetic rats. Free Radic Biol Med 26:538-547
24. van Zandt MC, Jones ML, Gunn DE, Geraci LS, Jones JH, Sawicki DR, Sredy J, Jacot JL, Dicioccio AT, Petrova T, Mitschler A, Podjamy AD (2005) Discovery of 3-[(4,5,7-trifluorobenzothiazol-2-yl)methyl]indole-N-acetic acid (lidorestat) and congeners as highly potent and selective inhibitors of aldose reductase for treatment of chronic diabetic complications. J Med Chem 48:3141-3152
25. Venkat Ratnam D, Ankola DD, Bhardwaj V, Sahana DK, Ravi Kumar MNV (2006) Role of antioxidants in prophylaxis and therapy: a pharmaceutical perspective. J Control Release 113:189-207
26. Waris G, Ahsan H (2006) Reactive oxygen species: role in the development of cancer and various chronic conditions. J Carcinogen 5:14